Dr. Hani Goodarzi is an Associate Professor and a Chan Zuckerberg Biohub Investigator at the University of California, San Francisco. With a dual background in computational and experimental genomics, he brings a multidisciplinary approach to studying complex human diseases. His research is focused on developing novel discovery platforms that help reveal previously unknown molecular mechanisms underlying cancer progression and neurodegeneration. By developing novel technologies for genome-wide measurement of hard-to-quantify RNA molecules, he has also made key discoveries about the role of non-coding RNAs in cancer progression. On the computational front, Dr. Goodarzi is focused on building biology-inspired and genome-scale machine learning models that help decode the biology of human genome. Most recently, for his contributions to cancer research, he was awarded the Vilcek Prize for Creative Promise and AACR-MPM Transformative Cancer Research Award. He was previously a recipient of the Martin and Rose Wachtel Award in Cancer Research and an American Cancer Society scholar.